Incidental Diagnosis of Metastatic Breast Cancer in a Man With 99m Tc-PSMA SPECT/CT.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 Apr 2023
01 Apr 2023
Historique:
pubmed:
3
2
2023
medline:
4
3
2023
entrez:
2
2
2023
Statut:
ppublish
Résumé
Breast cancer in men is a rare and unsuspected malignancy. A 48-year-old man begins with disabling low back pain. The CT scan reported a compression fracture in L2 and diffuse skeletal lesions suggestive of metastatic disease. The serum prostate-specific antigen was 6.2 ng/mL. He was referred for SPECT/CT with 99m Tc-EDDA/HYNIC-inhibitor prostate-specific membrane antigen due to clinical suspicion of prostate cancer. SPECT/CT with 99m Tc-EDDA/HYNIC-inhibitor prostate-specific membrane antigen showed a primary lesion in the left breast and multiple bone lesions. Biopsy confirmed infiltrating ductal carcinoma with positive hormone receptors and indeterminate HER2 (human epidermal growth factor receptor 2).
Identifiants
pubmed: 36728144
doi: 10.1097/RLU.0000000000004549
pii: 00003072-202304000-00032
doi:
Substances chimiques
EDDA
5657-17-0
Technetium
7440-26-8
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e163-e164Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Anderson WF, Jatoi I, Tse J, et al. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol . 2010;28:232–239.
Kinoshita Y, Kuratsukuri K, Landas S, et al. Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J Surg . 2006;30:628–636.
Unger C, Bronsert P, Michalski K, et al. Expression of prostate specific membrane antigen (PSMA) in breast cancer. Geburtshilfe Frauenheilkd . 2022;82:50–58.
Kasoha M, Unger C, Solomayer E-F, et al. Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases. Clin Exp Metastasis . 2017;34:479–490.
Wernicke AG, Varma S, Greenwood EA, et al. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. APMIS . 2014;122:482–489.
Tolkach Y, Gevensleben H, Bundschuh R, et al. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy. Breast Cancer Res Treat . 2018;169:447–455.
Medina-Ornelas S, García-Perez F, Estrada-Lobato E, et al. 68 Ga-PSMA PET/CT in the evaluation of locally advanced and metastatic breast cancer, a single center experience. Am J Nucl Med Mol Imaging . 2020;10:135–142.
Fallahi B, Khademi N, Karamzade-Ziarati N, et al. 99m Tc-PSMA SPECT/CT versus 68 Ga-PSMA PET/CT in the evaluation of metastatic prostate Cancer. Clin Nucl Med . 2021;46:e68–e74.
Marafi F, Sasikumar A, Alfeeli M, et al. 18 F-PSMA 1007 uptake in a man with metastatic breast cancer. Clin Nucl Med . 2020;45:e276–e278.
Kumar R, Mittal BR, Bhattacharya A, et al. Synchronous detection of male breast cancer and prostatic cancer in a patient with suspected prostatic carcinoma on 68 Ga-PSMA PET/CT imaging. Clin Nucl Med . 2018;43:431–432.
Polverari G, Ceci F, Calderoni L, et al. Male breast cancer detected by 68 Ga-PSMA-11 PET/CT in a patient with prostate cancer with pelvic lymph node metastasis. Clin Genitourin Cancer . 2019;17:154–156.
Kaewput C, Vinjamuri S. Update of PSMA theranostics in prostate cancer: current applications and future trends. J Clin Med . 2022;11:2738.
Jokar N, Velikyan I, Ahmadzadehfar H, et al. Theranostic approach in breast cancer: a treasured tailor for future oncology. Clin Nucl Med . 2021;46:e410–e420.